Physician

Anthony Degennaro, MD FACS

According to 2025 Medicare claims, Anthony Degennaro, MD FACS (NPI: 1528137262) practices otolaryngology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is ATLANTIC ENT GROUP LLC (NPI: 1629294079; TIN: 208403533) and primary practice location at 07701-1864.

Degennaro's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 302 traditional Medicare patients, billed 1,724 HCPCS/CPT codes, and received $142,690 in Medicare payments. The top billing code was 31231 (Diagnostic exam of nasal passages using an endoscope). Part D data shows 235 prescription claims across 116 beneficiaries totaling $6,017 in drug costs, led by Ciprofloxacin-Dexamethasone (Ciprofloxacin Hcl/Dexameth). 2019 DME data shows 37 claims. Open Payments data shows 2 records totaling $177. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $281,878 to $142,690. Similarly, Part D prescription costs have declined steadily, from $19,487 to $6,017. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $1,094 to $253.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	800	3,718	$281,878
2016	790	3,662	$283,826
2017	695	3,281	$251,649
2018	573	2,571	$176,092
2019	574	2,343	$156,304
2020	445	1,708	$111,317
2021	308	1,243	$113,979
2022	331	1,384	$119,815
2023	358	2,000	$167,014
2024	302	1,724	$142,690

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	199	408	$19,487
2016	226	444	$18,338
2017	170	352	$17,449
2018	133	282	$12,044
2019	166	317	$18,904
2020	136	313	$20,378
2021	105	211	$10,894
2022	111	224	$12,331
2023	118	217	$10,338
2024	116	235	$6,017

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	34	$349
2016	N/R	23	$240
2017	N/R	35	$722
2018	N/R	22	$433
2019	N/R	37	$3,894
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31231	Diagnostic exam of nasal passages using an endoscope	78	146	$140
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	143	277	$94
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	53	53	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	195	343	$63
69210	Removal of impacted ear wax	246	410	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	19	315	$2,015
Azelastine-Fluticasone	Azelastine/Fluticasone	14	400	$1,093
Ipratropium Bromide	Ipratropium Bromide	22	632	$563
Cefdinir	Cefdinir	32	329	$451
Methylprednisolone	Methylprednisolone	27	158	$201

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$177	Davol Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anthony Degennaro, MD FACS?

Tedicare shows public-source Medicare data for Anthony Degennaro, MD FACS (NPI 1528137262), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony Degennaro, MD FACS have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anthony Degennaro, MD FACS?

Anthony Degennaro, MD FACS is linked to ATLANTIC ENT GROUP LLC (billing NPI 1629294079) in the available physician profile data.

Does Anthony Degennaro, MD FACS have Open Payments data?

Anthony Degennaro, MD FACS has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.